Akèy › Leukemi limfoblastik ak limfom selil T prekursè › Tennessee
Etid klinik pou Leukemi limfoblastik ak limfom selil T prekursè nan Tennessee
3 etid pou Leukemi limfoblastik ak limfom selil T prekursè ap chèche patisipan nan sit nan Tennessee.
Tèks ofisyèl etid la (Anglè)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
Ap rekriteFaz 2
6 Months · Tout sèks · Mizajou Sep 28, 2026 · NCT06514794Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 2
Laj 1 a 18 · Tout sèks · Mizajou Aug 10, 2026 · NCT06390319CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
- St Jude Children's Research Hospital, Memphis
- St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1
Jiska laj 21 · Tout sèks · Mizajou May 19, 2026 · NCT04318678Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.